These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2862089)

  • 1. Salazopyrin in the management of Crohn's disease. The Japanese Research Committee for Crohn's disease.
    Gastroenterol Jpn; 1985 Feb; 20(1):71-81. PubMed ID: 2862089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythema nodosum and Crohn's disease].
    Areias E; García E Silva L
    Med Cutan Ibero Lat Am; 1984; 12(6):489-95. PubMed ID: 6152299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study.
    Anthonisen P; Barany F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H
    Scand J Gastroenterol; 1974; 9(6):549-54. PubMed ID: 4153646
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation].
    Anthonisen P; Bárány F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H
    Ugeskr Laeger; 1974 Aug; 136(32):1798-802. PubMed ID: 4153180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis].
    Stöcker W; Otte M; Ulrich S; Normann D; Stöcker K; Jantschek G
    Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1963-9. PubMed ID: 6150841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Crohn's disease. Has there been progress in its treatment?].
    Berenguer J
    Med Clin (Barc); 1984 Jun; 83(2):61-4. PubMed ID: 6147447
    [No Abstract]   [Full Text] [Related]  

  • 7. Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
    Banatwala N
    J Pak Med Assoc; 1985 Mar; 35(3):64-8. PubMed ID: 2860256
    [No Abstract]   [Full Text] [Related]  

  • 8. [A young woman with Crohn's disease of the esophagus].
    Leurs PB; Mulder AW; Bartelsman JW
    Ned Tijdschr Geneeskd; 1987 May; 131(22):955-8. PubMed ID: 2885763
    [No Abstract]   [Full Text] [Related]  

  • 9. [New forms of 5-aminosalicylate in inflammatory intestinal lesions].
    Gendre JP
    Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):337-41. PubMed ID: 2892459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial.
    Wenckert A; Kristensen M; Eklund AE; Barany F; Jarnum S; Worning H; Folkenborg O; Holtz A; Bonnevie O; Riis P
    Scand J Gastroenterol; 1978; 13(2):161-7. PubMed ID: 24891
    [No Abstract]   [Full Text] [Related]  

  • 11. Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease.
    Bergman L; Krause U
    Scand J Gastroenterol; 1976; 11(7):651-6. PubMed ID: 11545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotumor of the orbit and Crohn's disease.
    Verbraeken H; Ryckaert S; Demets W
    Bull Soc Belge Ophtalmol; 1984; 210():65-72. PubMed ID: 6152753
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pyoderma gangrenosum and Crohn's disease].
    Siragusa G; Aragona S; Guttadauro G; Di Vita G; Di Pace G
    Minerva Chir; 1990 Apr; 45(7):505-8. PubMed ID: 1973531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical, endoscopic and pathologic features of Crohn's disease in the differentiation from intestinal tuberculosis].
    Cheng L; Huang MF; Mei PF; Bo WH; Deng CS
    Zhonghua Nei Ke Za Zhi; 2013 Nov; 52(11):940-4. PubMed ID: 24439188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of Crohn's disease: relationship of disease type and severity to clinical findings at the time of diagnosis in 166 cases].
    Tominaga M
    Fukuoka Igaku Zasshi; 1992 Jan; 83(1):6-20. PubMed ID: 1547990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study.
    Van Hees PA; Van Lier HJ; Van Elteren PH; Driessen M; Van Hogezand RA; Ten Velde GP; Bakker JH; Van Tongeren JH
    Gut; 1981 May; 22(5):404-9. PubMed ID: 6114023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Crohn's disease: Vulvar edema and swelling].
    Abdou A; Zaouri H; El Moussaoui N; Senouci K; Hassam B; Ismaili N
    Presse Med; 2016 Mar; 45(3):371-2. PubMed ID: 26830925
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are there new viewpoints in the treatment of Crohn disease?].
    Malchow H
    Internist (Berl); 1982 Dec; 23(12):698-702. PubMed ID: 6131049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.